Francisco Cuevas

Francisco Cuevas

Auto-generated profile, based on publicly available information

Francisco Cuevas

Department of Medicine, Icahn School of Medicine at Mount Sinai, NYC Health+Hospitals, Queens, NY, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in Medicine
Verified
Journal Article
Open access
MNMahmoud Nassar
Mahmoud Nassar
VGVictoria Ghernautan
Victoria Ghernautan
NNNso Nso
Nso Nso
ANAkwe Nyabera
Akwe Nyabera
FCFrancisco Cuevas Castillo
Francisco Cuevas Castillo
MEMohamed El-Kassas
Mohamed El-Kassas
The gastrointestinal tract (GI) is the second most affected organ system in individuals suffering from systemic/localized scleroderma (SSc) or localized scleroderma. SSc can affect any part of the GI, between the oral cavity and anorectum. The annual incidence of SSc in the United States is estimated to be 19.3 cases per million adults, with the highest incidence reported in people aged 44 to 55. Females are 5 times more likely than males to suffer from SSc. Morbidity and mortality rates associated with SSc are predominantly elevated among patients with GI manifestations. Esophageal and intestinal manifestations impact 90% and 40% to 70% of patients with systemic scleroderma, respectively. SSc patients are known to suffer from small bowel hypomotility and small intestinal bacterial overgrowth, which cause malabsorption and malnutrition, ultimately contributing to the 50% mortality rate. Fecal incontinence is a common symptom of SSc that can lead to depression. SSc patients may suffer from gastrointestinal complications that can negatively impact their quality of life on a daily basis. Multidisciplinary approaches are necessary for systematically managing gastrointestinal complications associated with SSc. A prospective study should focus on developing targeted therapies to improve recovery patterns and prognosis in cases of SSc. This article summarizes the epidemiology, commonly reported clinical manifestations, complications, and available treatments for treating GI pathology in SSc patients.

1 October 2021 in Journal of Infection and Public Health
Verified
Journal Article
Open access
JKJoyce Kong
Joyce Kong
FCFrancisco Cuevas-Castillo
Francisco Cuevas-Castillo
MNMahmoud Nassar
Mahmoud Nassar
CLChi M. Lei
Chi M. Lei
ZIZarwa Idrees
Zarwa Idrees
AMAlwin Mathew
Alwin Mathew
In December 2020, Moderna released the mRNA-1273 vaccine. The most common side effects are headache, muscle pain, redness, swelling, and tenderness at the injection site. In addition, there have been dermatological adverse events, such as hypersensitivity reactions. Although rare, various bullous eruptions have been described following vaccination. Bullous pemphigoid has been reported to occur most often after receipt of influenza and the diphtheria-tetanus-pertussis vaccine. To the best of our knowledge, there have been no reports of bullous drug eruptions resulting from mRNA vaccines. A 66-years-old obese Guyanese male presented with a bullous rash following receipt of a commercial COVID-19 mRNA vaccine. He received the first dose uneventfully. However, within 24 hours of receiving the second dose, he developed fever, myalgias, and malaise accompanied by a painful blistering rash of his torso, arms, and legs. His fever and myalgias improved after 24 hours, but his painful rash did not, and five days after the initial symptoms, he presented to the hospital. There were many violaceous, poorly demarcated patches on his trunk, arms, and thighs on examination, many of which had large flaccid bullae within, and a few areas on his buttocks, posterior shoulder, and scrotum were eroded. The exam was also significant for lower extremity muscle tenderness, stiffness with preserved strength. A skin biopsy showed epidermal necrosis and sparse perivascular dermatitis concerning Stevens-Johnson syndrome or erythema multiforme. However, in the absence of mucous membrane involvement or targetoid lesions, the diagnosis of an extensive bullous fixed drug eruption was made. This case illustrates that the bullae eruption occurred as a result of receiving the Moderna vaccination.

15 July 2020 in Cureus
Verified
Journal Article
Open access
PDF file
FCFrancisco J. Cuevas Castillo
Francisco J. Cuevas Castillo
SSSunam Sujanani
Sunam Sujanani
VCVishaka K. Chetram
Vishaka K. Chetram
MEMohanad Elfishawi
Mohanad Elfishawi
AAAdriana Abrudescu
Adriana Abrudescu
Monckeberg medial calcific sclerosis (MCS) is an infrequent finding in the temporal artery and can clinically present almost indistinguishably from giant cell arteritis (GCA). To our knowledge, there have been only two case reports of suspected GCA found to be MCS only after a temporal artery biopsy (TAB). Herein, we present two cases. The first case is a 69-year-old female with hypertension, type-2 diabetes mellitus, and chronic headaches who presented with left temporal headaches and scalp tenderness. She had a prominently dilated, tortuous, and tender left temporal artery. Initial labs showed a leukocyte count of 11.1x103/L, erythrocyte sedimentation rate (ESR) of 29 mm/hr, and C-reactive protein (CRP) of 5.8 mg/L. The patient was started on prednisone 60 mg for presumptive GCA. Left TAB was negative for inflammatory changes, with findings consistent with MCS. Steroids were discontinued, and symptoms resolved. The second case is a 67-year-old male with hypertension, asthma, hyperlipidemia, status-post left eye cataract phacoemulsification, with intraocular lens insertion one-month prior, who presented with left eye blurriness in the inferior visual field and intermittent headache for 15 days. Left ophthalmoscopy showed retinal pallor and edema. Initial labs revealed ESR of 25 mm/hr, CRP of 11.2 mg/L, leukocyte count of 13.01x103/L. The patient was given solumedrol 120 mg once and prednisone 70 mg daily for presumptive GCA. Left TAB was negative for GCA but reported damaged elastic fibers by calcification consistent with MCS. Partial visual blurriness remained, and steroids were discontinued. This report accentuates the importance of MCS as a temporal GCA simulator. Physicians should be aware that TAB potentially changes management and may help surface underlying conditions.

1 January 2018 in Archives of Medical Research
Verified
Journal Article
Closed access
EYEmiy Yokoyama
Emiy Yokoyama
MCMargarita Chávez-Saldaña
Margarita Chávez-Saldaña
LOLorena Orozco
Lorena Orozco
FCFrancisco Cuevas
Francisco Cuevas
JLJosé Luis Lezana
José Luis Lezana
Daniel Adrian Landero HuertaDaniel Adrian Landero Huerta
Daniel Adrian Landero Huerta

16 November 2020 in Case Reports in Gastrointestinal Medicine
Verified
Journal Article
Open access
PDF file
ANAkwe Nyabera
Akwe Nyabera
MEMohanad Elfishawi
Mohanad Elfishawi
FCFrancisco Cuevas
Francisco Cuevas
FRFahad Riaz
Fahad Riaz
AAAdriana Abrudescu
Adriana Abrudescu
Intestinal pseudo-obstruction (IPO) is a rarely recognized complication of systemic lupus erythematosus (SLE). We present a 36-year-old African American female, with only known past medical history of anemia, admitted for frequent vomiting, abdominal distension, abdominal pain, diarrhea, and fever that had been ongoing for 5 days. Laboratory results revealed leukopenia and thrombocytopenia. Imaging revealed dilated small bowel loops, abdominal ascites, as well as mild bilateral hydroureteronephrosis without obstructing calculus. Serologic testing confirmed a diagnosis of SLE. The patient was placed on immunosuppressive therapy and responded well. IPO has previously been described as a rare finding in patients with SLE, with bilateral hydroureteronephrosis and lupus interstitial cystitis having been noted as common concomitant factors. One must have a high level of suspicion to recognize it as being one of the initial clinical presentations. Early recognition and appropriate management preclude unnecessary invasive procedures that do not take into account the pathophysiology of the condition and allow for appropriate management and return of peristaltic function.

27 May 2020
Verified
Conference Paper
Open access
CGChandan Buttar Gakhal
Chandan Buttar Gakhal
FCFrancisco Javier Cuevas Castillo
Francisco Javier Cuevas Castillo
Introduction Posterior reversible encephalopathy syndrome (PRES) is a clinical pattern of headache, altered mental status, change in vision and s |